BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10163465)

  • 1. Long-term results of pars plana vitrectomy in the management of intermediate uveitis.
    Heiligenhaus A; Bornfeld N; Wessing A
    Curr Opin Ophthalmol; 1996 Jun; 7(3):77-9. PubMed ID: 10163465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pars plana vitrectomy in patients with intermediate uveitis.
    Stavrou P; Baltatzis S; Letko E; Samson CM; Christen W; Foster CS
    Ocul Immunol Inflamm; 2001 Sep; 9(3):141-51. PubMed ID: 11815883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term results of pars plana vitrectomy as an anti-inflammatory therapy of pediatric intermediate uveitis resistant to standard medical treatment.
    Darsová D; Pochop P; Štěpánková J; Dotřelová D
    Eur J Ophthalmol; 2018 Jan; 28(1):98-102. PubMed ID: 28862736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results of pars plana vitrectomy in the management of complicated uveitis.
    Heiligenhaus A; Bornfeld N; Foerster MH; Wessing A
    Br J Ophthalmol; 1994 Jul; 78(7):549-54. PubMed ID: 7918267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitrectomy for juvenile uveitis: prognostic factors for the long-term functional outcome.
    Trittibach P; Koerner F; Sarra GM; Garweg JG
    Eye (Lond); 2006 Feb; 20(2):184-90. PubMed ID: 15803175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of pars plana vitrectomy in chronic uveitis in childhood].
    Bacskulin A; Eckardt C
    Ophthalmologe; 1993 Oct; 90(5):434-9. PubMed ID: 8219626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune modulator therapy compared with vitrectomy for management of complicated intermediate uveitis: a prospective, randomized clinical study.
    Shalaby O; Saeed A; Elmohamady MN
    Arq Bras Oftalmol; 2020; 83(5):402-409. PubMed ID: 33084818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of pars plana vitrectomy on cystoid macular oedema associated with chronic uveitis: a randomised, controlled pilot study.
    Tranos P; Scott R; Zambarakji H; Ayliffe W; Pavesio C; Charteris DG
    Br J Ophthalmol; 2006 Sep; 90(9):1107-10. PubMed ID: 16723360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pars plana vitrectomy for cystoid macular edema secondary to sarcoid uveitis.
    Kiryu J; Kita M; Tanabe T; Yamashiro K; Miyamoto N; Ieki Y
    Ophthalmology; 2001 Jun; 108(6):1140-4. PubMed ID: 11382643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Early vitrectomy in endogenous juvenile uveitis intermedia--a long-term study].
    Kroll P; Romstöck F; Grenzebach UH; Wiegand W
    Klin Monbl Augenheilkd; 1995 Apr; 206(4):246-9. PubMed ID: 7791284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pars-plana vitrectomy in cystoid macular edema associated with intermediate uveitis.
    Wiechens B; Nölle B; Reichelt JA
    Graefes Arch Clin Exp Ophthalmol; 2001 Jul; 239(7):474-81. PubMed ID: 11521690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pars plana vitrectomy in uveitis].
    Bovey EH; Gonvers M; Herbort CP
    Klin Monbl Augenheilkd; 1992 May; 200(5):464-7. PubMed ID: 1614127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pars plana vitrectomy as anti-inflammatory therapy for intermediate uveitis in children].
    Figueroa MS; Noval S; Contreras I; Arruabarrena C; García-Pérez JL; Sales M; Gil-Cazorla R
    Arch Soc Esp Oftalmol; 2010 Dec; 85(12):390-4. PubMed ID: 21354506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined extracapsular cataract extraction, posterior chamber intraocular lens implantation, and pars plana vitrectomy.
    Foster RE; Lowder CY; Meisler DM; Zakov ZN; Meyers SM; Ambler JS
    Ophthalmic Surg; 1993 Jul; 24(7):446-52. PubMed ID: 8351090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical management of retinal diseases: proliferative diabetic retinopathy and traction retinal detachment.
    Cruz-Iñigo YJ; Acabá LA; Berrocal MH
    Dev Ophthalmol; 2014; 54():196-203. PubMed ID: 25196770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitrectomy for Epiretinal Membranes and Macular Holes in Uveitis Patients.
    Branson SV; McClafferty BR; Kurup SK
    J Ocul Pharmacol Ther; 2017 May; 33(4):298-303. PubMed ID: 28112568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pars plana vitrectomy versus immunomodulatory therapy for intermediate uveitis: a prospective, randomized pilot study.
    Quinones K; Choi JY; Yilmaz T; Kafkala C; Letko E; Foster CS
    Ocul Immunol Inflamm; 2010 Oct; 18(5):411-7. PubMed ID: 20735289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of presumed trematode-induced granulomatous intermediate uveitis.
    Amin RH; Abdullatif AM
    Eye (Lond); 2023 Aug; 37(11):2299-2304. PubMed ID: 36477731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic pars plana vitrectomy for chronic uveitis: a retrospective study of the long-term results.
    Verbraeken H
    Graefes Arch Clin Exp Ophthalmol; 1996 May; 234(5):288-93. PubMed ID: 8740248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual outcome of patients with macular edema after pars plana vitrectomy and indocyanine green-assisted peeling of the internal limiting membrane.
    Radetzky S; Walter P; Fauser S; Koizumi K; Kirchhof B; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2004 Apr; 242(4):273-8. PubMed ID: 15042375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.